Skip to main content
. 2021 Jul 9;10(7):1593. doi: 10.3390/foods10071593

Table 2.

Recovery (%) of the most abundant betalain and phenolic compounds in Opuntia stricta var. Dillenii fruit tissues (peel, pulp, and whole fruit). Jam production products (intermediate juice and jam) and by-products (bagasse) during in vitro gastrointestinal static digestion.

Recovery (%)
Compound In Vitro phase Fresh Whole Fruit (FWF) Fresh Peel (PE) Fresh Pulp (PU) Bagasse
By-Product (BA)
Fresh Pressed Juice (JU) Jam (JA)
BETALAINS
Betanin Oral 80.10 ± 2.79 Bc 101.71 ± 7.59 Ce 60.58 ± 1.90 Bb 52.25 ± 1.06 Ba 99.43 ± 1.52 Bd n.d.
Gastric 75.16 ± 0.88 Bc 94.00 ± 1.69 Bd 57.31 ± 0.27 Cb 49.87 ± 1.60 Ca 96.34 ± 2.03 Bd n.d.
Intestinal 22.42 ± 1.29 Aab 42.58 ± 3.35 Ac 22.95 ± 0.01 Aab 19.03 ± 1.14 Aa 28.53 ± 2.19 Ab n.d.
Isobetanin Oral 71.07 ± 3.63 Bc 166.33± 8.32 Ce 53.03 ± 2.01 Bb 33.54 ± 1.27 Ba 90.98 ± 1.61 Bd n.d.
Gastric 76.78 ± 0.25 Bc 104.11 ± 3.27 Be 60.38 ± 0.18 ab 52.11 ± 1.99 Ca 97.22 ± 2.11 Bd n.d.
Intestinal 22.85 ± 1.72 Ab 45.67 ± 1.66 Ac 23.60 ± 0.06 Ab 18.52 ± 1.20 Aa 26.44 ± 2.42 Ab n.d.
Betanidin Oral 155.11 ± 0.02 Be 78.52 ± 3.93 Cb 84.72 ± 2.75 Bc 30.90 ± 0.18 Ba 109.82 ± 2.50 Bd n.d.
Gastric 157.49 ± 10.63 Be 46.49 ± 2.32 Ba 91.85 ± 1.55 Cb 45.78 ± 2.22 Ca 112.93 ± 1.42 Bc n.d.
Intestinal 47.06 ± 0.77 Ae 21.74 ± 1.09 Ab 36.37 ± 0.35 Ad 10.38 ± 0.28 Aa 25.95 ± 3.14 Ac n.d.
2′-O-apiosyl-4-O-phyllocactin Oral 65.09 ± 4.59 Bd 149.40 ± 7.49 Cf 47.00 ± 1.61 Bc 31.01 ± 0.34 Bb 103.51 ± 2.11 Ae 10.38 ± 1.35 Ba
Gastric 65.09± 4.05 Bc 90.58 ± 0.48 Bd 50.85 ± 0.01 Cc 34.61 ± 1.73 Cb 100.74 ± 2.85 Ad 16.12 ± 0.88 Ca
Intestinal 20.42 ± 4.04 Ab 41.32 ± 0.78 Ac 5.97 ± 0.30 Aa 21.94 ± 0.71 Ab 0 0
Neobetanin Oral 67.96 ± 9.33 Bb 116.94 ± 5.85 Cc 61.92 ± 6.48 Bb 41.14 ± 1.63 Ba 110.47 ± 2.57 Cc n.d.
Gastric 60.08 ± 9.70 Cbc 112.27 ± 5.61 Bc 62.41 ± 4.45 Ba 48.74 ± 3.13 Ca 94.78 ± 3.16 Bb n.d.
Intestinal 7.63 ± 2.96 Ab 23.26 ± 1.16 Ac 26.22 ± 2.90 Ac 3.08 ± 0.15 Aab 7.20 ± 0.52 Ab n.d.
PHENOLICS ACIDS
Piscidic acid Oral 70.82 ± 2.74 Bd 111.92 ± 5.60 Ce 21.39 ± 0.96 Ba 44.39 ± 0.87 Bc 33.80 ± 1.19 Ab 23.16 ± 2.02 Aa
Gastric 81.49 ± 7.81A Bc 75.26 ± 2.39 Bc 19.34 ± 0.74 Ba 53.09 ± 1.72 Cb 46.11 ± 0.19 Ab 33.20 ± 0.79 Bb
Intestinal 61.35 ± 3.07 Ae 40.71 ± 2.78 Ad 7.43 ± 0.35 Ab 2.03 ± 0.08 Aa 44.17 ± 1.78 Ad 18.13 ± 0.97 Ac
FLAVONOIDS
Quercetin glycoside(QG1)—Quercetin hexosyl pentosyl rhamnoside Oral 105.65 ± 0.07 Cd 137.98 ± 6.90 Ce n.d. 0 63.53 ± 0.44 Bc 9.86 ± 0.92 Bb
Gastric 90.21 ± 0.84 Bd 86.35 ± 1.72 Bd n.d. 0 68.36 ± 2.54 Bc 14.76 ± 0.80 Cb
Intestinal 28.33 ± 2.18 Ab 53.72 ± 5.19 Ad n.d. 0 45.38 ± 1.78 Ac 7.15 ± 0.36Aa
Isorhamnetin glucoxyl-rhamnosyl-rhamnoside (IG1) Oral 81.74 ± 2.07 Cc 158.05 ± 7.54 Cd 0 n.d. 68.15 ± 8.04 Bb 11.39 ± 2.81 Ba
Gastric 64.82 ± 2.28 Bc 80.77 ± 1.00 Bd 0 n.d. 94.36 ± 0.91 Ce 16.36 ± 3.49 Bb
Intestinal 15.27 ± 0.88 Ab 30.62 ± 0.98 Ac 0 n.d. 29.43 ± 3.51 Ac 0.00 ± 0.00 Aa
Isorhamnetin glucoxyl-rhamnosyl-pentoside (IG2) Oral 75.43 ± 14.17 Bc 148.28 ± 7.41 Cd 68.56 ± 12.80 Ac 35.45 ± 1.44 Bb 94.44 ± 2.76 Bc 0.94 ± 0.20 Aa
Gastric 74.74 ± 4.14 Bc 101.38 ± 0.97 Bd 136.88 ± 4.33 Be 56.20 ± 2.75 Cb 109.25 ± 0.90 Cd 1.33 ± 0.20 Aa
Intestinal 20.02 ± 2.95 Ab 41.40 ± 1.09 Ac 37.77 ± 1.85 Ac 18.49 ± 1.85 Ab 36.33 ± 1.34 Ac 0.81 ± 0.24 Aa

Results were expressed as mean ± standard deviation (n = 4). This came from obtaining at least two independent extracts (n = 2) and performing the HPLC determinations of each two times (n = 2). Superscript capital letters indicate statistically significant differences (p ≤ 0.05) between digestion phases. Superscript small letters indicate statistically significant differences (p ≤ 0.05) between tissues, products, and by-products.